HealthStream (HSTM) Q3 2024 earnings summary

Executive summary

• Q3 2024 revenues reached $73.1 million, up 3.9% year-over-year, with record adjusted EBITDA of $17.7 million and net income up 48% to $5.7 million; diluted EPS rose to $0.19 from $0.13.

• 96% of revenues are subscription-based, providing stable, recurring income streams.

• Expanded direct sales channels to healthcare professionals and nursing students, with a strong cash balance of $94.9 million and no debt.

• Launched new products and features, including Insights+ for analytics, Provider Portfolio, and expanded into new markets such as health plans and nursing schools.

• Focused on One HealthStream platform strategy, leveraging hStream technology for interoperability and value enhancement.

Financial highlights

• Q3 2024 revenues were $73.1 million, up 3.9% year-over-year; adjusted EBITDA was $17.7 million, up 9%, with a margin of 24.2%.

• Net income for Q3 2024 was $5.7 million, up 48% year-over-year; operating income rose 33.6% to $6.5 million.

• Subscription revenues were $69.9 million (96% of total), up 3.6%; professional services revenues were $3.2 million, up 10.8%.

• Gross margin for Q3 2024 was 66.5%.

• Cash and investments at quarter-end were $94.9 million, with no debt and a $50 million unused credit facility.

Outlook and guidance

• Full-year 2024 revenue guidance revised to $290–$292 million, slightly lower due to a large customer’s slower content consumption.

• Net income expected between $18.5–$19.5 million; Adjusted EBITDA between $66–$67.5 million.

• Capital expenditures expected to be $28–$30 million.

• Medium-term objectives: annual revenue growth of 7–10%, gross margin of 65–68%, and adjusted EBITDA margin of 21–24%.

• Management expects strong sales pipelines and sufficient liquidity for operations, development, and dividends.